Cargando…

Serum and urine FGF23 and IGFBP-7 for the prediction of acute kidney injury in critically ill children

BACKGROUND: Fibroblast growth factor 23 (FGF23) and insulin-like growth factor binding protein 7 (IGFBP-7) are suggested to be biomarkers for predicting acute kidney injury (AKI). We compared them with proposed AKI biomarker of cystatin C (CysC), and aimed (1) to examine whether concentrations of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Zhenjiang, Fang, Fang, Xu, Zhong, Lu, Chunjiu, Wang, Xueqin, Chen, Jiao, Pan, Jian, Wang, Jian, Li, Yanhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004091/
https://www.ncbi.nlm.nih.gov/pubmed/29907141
http://dx.doi.org/10.1186/s12887-018-1175-y
_version_ 1783332464333160448
author Bai, Zhenjiang
Fang, Fang
Xu, Zhong
Lu, Chunjiu
Wang, Xueqin
Chen, Jiao
Pan, Jian
Wang, Jian
Li, Yanhong
author_facet Bai, Zhenjiang
Fang, Fang
Xu, Zhong
Lu, Chunjiu
Wang, Xueqin
Chen, Jiao
Pan, Jian
Wang, Jian
Li, Yanhong
author_sort Bai, Zhenjiang
collection PubMed
description BACKGROUND: Fibroblast growth factor 23 (FGF23) and insulin-like growth factor binding protein 7 (IGFBP-7) are suggested to be biomarkers for predicting acute kidney injury (AKI). We compared them with proposed AKI biomarker of cystatin C (CysC), and aimed (1) to examine whether concentrations of these biomarkers vary with age, body weight, illness severity assessed by pediatric risk of mortality III score, and kidney function assessed by estimated glomerular filtration rate (eGFR), (2) to determine the association between these biomarkers and AKI, and (3) to evaluate whether these biomarkers could serve as early independent predictors of AKI in critically ill children. METHODS: This prospective single center study included 144 critically ill patients admitted to the pediatric intensive care unit (PICU) regardless of diagnosis. Serum and spot urine samples were collected during the first 24 h after PICU admission. AKI was diagnosed based on the AKI network (AKIN) criteria. RESULTS: Twenty-one patients developed AKI within 120 h of sample collection, including 11 with severe AKI defined as AKIN stages 2 and 3. Serum FGF23 levels were independently associated with eGFR after adjustment in a multivariate linear analysis (P < 0.001). Urinary IGFBP-7 (Adjusted OR = 2.94 per 1000 ng/mg increase, P = 0.035), serum CysC (Adjusted OR = 5.28, P = 0.005), and urinary CysC (Adjusted OR = 1.13 per 1000 ng/mg increase, P = 0.022) remained significantly associated with severe AKI after adjustment for body weight and illness severity, respectively. Urinary IGFBP-7 level was predictive of severe AKI and achieved the AUC of 0.79 (P = 0.001), but was not better than serum (AUC = 0.89, P < 0.001) and urinary (AUC = 0.88, P < 0.001) CysC in predicting severe AKI. CONCLUSIONS: Serum FGF23 levels were inversely related to measures of eGFR. In contrast to serum and urinary FGF23 which are not associated with AKI in a general and heterogeneous PICU population, an increased urinary IGFBP-7 level was independently associated with the increased risk of severe AKI diagnosed within the next 5 days after sampling, but not superior to serum or urinary CysC in predicting severe AKI in critically ill children.
format Online
Article
Text
id pubmed-6004091
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60040912018-06-26 Serum and urine FGF23 and IGFBP-7 for the prediction of acute kidney injury in critically ill children Bai, Zhenjiang Fang, Fang Xu, Zhong Lu, Chunjiu Wang, Xueqin Chen, Jiao Pan, Jian Wang, Jian Li, Yanhong BMC Pediatr Research Article BACKGROUND: Fibroblast growth factor 23 (FGF23) and insulin-like growth factor binding protein 7 (IGFBP-7) are suggested to be biomarkers for predicting acute kidney injury (AKI). We compared them with proposed AKI biomarker of cystatin C (CysC), and aimed (1) to examine whether concentrations of these biomarkers vary with age, body weight, illness severity assessed by pediatric risk of mortality III score, and kidney function assessed by estimated glomerular filtration rate (eGFR), (2) to determine the association between these biomarkers and AKI, and (3) to evaluate whether these biomarkers could serve as early independent predictors of AKI in critically ill children. METHODS: This prospective single center study included 144 critically ill patients admitted to the pediatric intensive care unit (PICU) regardless of diagnosis. Serum and spot urine samples were collected during the first 24 h after PICU admission. AKI was diagnosed based on the AKI network (AKIN) criteria. RESULTS: Twenty-one patients developed AKI within 120 h of sample collection, including 11 with severe AKI defined as AKIN stages 2 and 3. Serum FGF23 levels were independently associated with eGFR after adjustment in a multivariate linear analysis (P < 0.001). Urinary IGFBP-7 (Adjusted OR = 2.94 per 1000 ng/mg increase, P = 0.035), serum CysC (Adjusted OR = 5.28, P = 0.005), and urinary CysC (Adjusted OR = 1.13 per 1000 ng/mg increase, P = 0.022) remained significantly associated with severe AKI after adjustment for body weight and illness severity, respectively. Urinary IGFBP-7 level was predictive of severe AKI and achieved the AUC of 0.79 (P = 0.001), but was not better than serum (AUC = 0.89, P < 0.001) and urinary (AUC = 0.88, P < 0.001) CysC in predicting severe AKI. CONCLUSIONS: Serum FGF23 levels were inversely related to measures of eGFR. In contrast to serum and urinary FGF23 which are not associated with AKI in a general and heterogeneous PICU population, an increased urinary IGFBP-7 level was independently associated with the increased risk of severe AKI diagnosed within the next 5 days after sampling, but not superior to serum or urinary CysC in predicting severe AKI in critically ill children. BioMed Central 2018-06-15 /pmc/articles/PMC6004091/ /pubmed/29907141 http://dx.doi.org/10.1186/s12887-018-1175-y Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Bai, Zhenjiang
Fang, Fang
Xu, Zhong
Lu, Chunjiu
Wang, Xueqin
Chen, Jiao
Pan, Jian
Wang, Jian
Li, Yanhong
Serum and urine FGF23 and IGFBP-7 for the prediction of acute kidney injury in critically ill children
title Serum and urine FGF23 and IGFBP-7 for the prediction of acute kidney injury in critically ill children
title_full Serum and urine FGF23 and IGFBP-7 for the prediction of acute kidney injury in critically ill children
title_fullStr Serum and urine FGF23 and IGFBP-7 for the prediction of acute kidney injury in critically ill children
title_full_unstemmed Serum and urine FGF23 and IGFBP-7 for the prediction of acute kidney injury in critically ill children
title_short Serum and urine FGF23 and IGFBP-7 for the prediction of acute kidney injury in critically ill children
title_sort serum and urine fgf23 and igfbp-7 for the prediction of acute kidney injury in critically ill children
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004091/
https://www.ncbi.nlm.nih.gov/pubmed/29907141
http://dx.doi.org/10.1186/s12887-018-1175-y
work_keys_str_mv AT baizhenjiang serumandurinefgf23andigfbp7forthepredictionofacutekidneyinjuryincriticallyillchildren
AT fangfang serumandurinefgf23andigfbp7forthepredictionofacutekidneyinjuryincriticallyillchildren
AT xuzhong serumandurinefgf23andigfbp7forthepredictionofacutekidneyinjuryincriticallyillchildren
AT luchunjiu serumandurinefgf23andigfbp7forthepredictionofacutekidneyinjuryincriticallyillchildren
AT wangxueqin serumandurinefgf23andigfbp7forthepredictionofacutekidneyinjuryincriticallyillchildren
AT chenjiao serumandurinefgf23andigfbp7forthepredictionofacutekidneyinjuryincriticallyillchildren
AT panjian serumandurinefgf23andigfbp7forthepredictionofacutekidneyinjuryincriticallyillchildren
AT wangjian serumandurinefgf23andigfbp7forthepredictionofacutekidneyinjuryincriticallyillchildren
AT liyanhong serumandurinefgf23andigfbp7forthepredictionofacutekidneyinjuryincriticallyillchildren